References
Aiyegbusi O, McGregor L, McGeoch L, Kipgen D, Geddes CC, & Stevens KI.
(2021). Renal Disease in Primary Sjogren’s Syndrome. Rheumatol Ther 8:
63-80.
Aldahlawi AM, Elshal MF, Ashgan FT, & Bahlas S. (2015). Chemokine
receptors expression on peripheral CD4-lymphocytes in rheumatoid
arthritis: Coexpression of CCR7 and CD95 is associated with disease
activity. Saudi J Biol Sci 22: 453-458.
Aldahlawi AM, Elshal MF, Damiaiti LA, Damanhori LH, & Bahlas SM.
(2016). Analysis of CD95 and CCR7 expression on circulating CD4(+)
lymphocytes revealed disparate immunoregulatory potentials in systemic
lupus erythematosus. Saudi J Biol Sci 23: 101-107.
Alwarith J, Kahleova H, Crosby L, Brooks A, Brandon L, Levin SM, et al.
(2020). The role of nutrition in asthma prevention and treatment. Nutr
Rev 78: 928-938.
Antonelli A, Ferrari SM, Giuggioli D, Ferrannini E, Ferri C, & Fallahi
P. (2014). Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune
diseases. Autoimmun Rev 13: 272-280.
Argyropoulou OD, Valentini E, Ferro F, Leone MC, Cafaro G, Bartoloni E,
et al. (2018). One year in review 2018: Sjogren’s syndrome. Clin Exp
Rheumatol 112: 14-26.
Averbeck M, Kuhn S, Buhligen J, Gotte M, Simon JC, & Polte T. (2017).
Syndecan-1 regulates dendritic cell migration in cutaneous
hypersensitivity to haptens. Exp Dermatol 26: 1060-1067.
Barone F, Bombardieri M, Manzo A, Blades MC, Morgan PR, Challacombe SJ,
et al. (2005). Association of CXCL13 and CCL21 expression with the
progressive organization of lymphoid-like structures in Sjogren’s
syndrome. Arthritis Rheum 52: 1773-1784.
Bombardieri M, & Pitzalis C. (2012). Ectopic lymphoid neogenesis and
lymphoid chemokines in Sjogren’s syndrome: at the interplay between
chronic inflammation, autoimmunity and lymphomagenesis. Curr Pharm
Biotechnol 13: 1989-1996.
Bunting MD, Comerford I, Seach N, Hammett MV, Asquith DL, Korner H, et
al. (2013). CCX-CKR deficiency alters thymic stroma impairing thymocyte
development and promoting autoimmunity. Blood 121: 118-128.
Cai QY, Liang GY, Zheng YF, Tan QY, Wang RW, & Li K. (2017). CCR7
enhances the angiogenic capacity of esophageal squamous carcinoma cells
in vitro via activation of the NF-kappaB/VEGF signaling pathway. Am J
Transl Res 9: 3282-3292.
Calabresi E, Petrelli F, Bonifacio AF, Puxeddu I, & Alunno A. (2018).
One year in review 2018: pathogenesis of rheumatoid arthritis. Clin Exp
Rhematol 36: 175-184.
Cardona AE, Sasse ME, Liu L, Cardona SM, Mizutani M, Savarin C, et al.
(2008). Scavenging roles of chemokine receptors: chemokine receptor
deficiency is associated with increased levels of ligand in circulation
and tissues. Blood 112: 256-263.
Carubbi F, Alunno A, Cipriani P, Di Benedetto P, Ruscitti P,
Berardicurti O, et al. (2014). Is minor salivary gland biopsy more than
a diagnostic tool in primary Sjogrens syndrome? Association between
clinical, histopathological, and molecular features: a retrospective
study. Semin. Arthritis Rheum 44: 314-324.
Cerezo LA, Vencovsky J, & Senolt L. (2020). Cytokines and inflammatory
mediators as promising markers of polymyositis/dermatomyositis. Curr
Opin Rheumatol 32: 534-541.
Chen P, Tao J, Zhu S, Cai Y, Mao Q, Yu D, et al. (2015). Radially
oriented collagen scaffold with SDF-1 promotes osteochondral repair by
facilitating cell homing. Biomaterials 39: 114-123.
Chen S, Wang Q, Wu CY, Wu QJ, Li Y, Wu ZY, et al. (2015). A
single-nucleotide polymorphism of CCL21 rs951005 T>C is
associated with susceptibility of polymyositis and such patients with
interstitial lung disease in a Chinese Han population. Clin Exp
Rheumatol 33: 639-646.
Ciccia F, Rizzo A, Maugeri R, Alessandro R, Croci S, Guggino G, et al.
(2017). Ectopic expression of CXCL13, BAFF, APRIL and LT-beta is
associated with artery tertiary lymphoid organs in giant cell arteritis.
Ann Rheum Dis 76: 235-243.
Comerford I, Harata-Lee Y, Bunting MD, Gregor C, Kara EE, & McColl SR.
(2013). A myriad of functions and complex regulation of the
CCR7/CCL19/CCL21 chemokine axis in the adaptive immune system. Cytokine
Growth Factor Rev 24: 269-283.
Cuesta-Mateos C, Lopez-Giral S, Alfonso-Perez M, de Soria VG,
Loscertales J, Guasch-Vidal S, et al. (2010). Analysis of migratory and
prosurvival pathways induced by the homeostatic chemokines CCL19 and
CCL21 in B-cell chronic lymphocytic leukemia. Exp Rhematol 38: 756-764.
e7644.
D’Agostino G, García-Cuesta EM, Gomariz RP, Rodríguez-Frade JM, Mellado
M. (2020). The multilayered complexity of the chemokine receptor system.
Biochem Biophys Res Commun 528: 347-358.
De Paepe B, Creus KK, & De Bleecker JL. (2009). Role of cytokines and
chemokines in idiopathic inflammatory myopathies. Curr Opin Rheumatol
21: 610-616.
Dong Z, Chen Y , Peng Y, Wang F, Yang Z, Huang G, et al. (2017).
Concurrent CCR7 Overexpression and RelB Knockdown in Immature Dendritic
Cells Induces Immune Tolerance and Improves Skin-Graft Survival in a
Murine Model. Cell Physiol Biochem 42: 455-468.
Fanouriakis A, Tziolos N, Bertsias G, & Boumpas DT. (2021). Update
omicronn the diagnosis and management of systemic lupus erythematosus.
Ann Rheum Dis 80: 14-25.
Favero M, Belluzzi E, Trisolino G, Goldring MB, Goldring SR, Cigolotti
A, et al. (2019). Inflammatory molecules produced by meniscus and
synovium in early and end-stage osteoarthritis: a coculture study. J
Cell Physiol 234: 11176-11187.
Feng X, Zhao C, Li L, Feng J, He W, Shi T, et al. (2021). iNKT cells
with high PLZF expression are recruited into the lung via CCL21-CCR7
signaling to facilitate the development of asthma tolerance in mice. Eur
J Immunol 51: 414-432.
Förster R, Davalos-Misslitz AC, & Rot A. (2008). CCR7 and its ligands:
balancing immunity and tolerance. Nat Rev Immunol 8: 362-371.
Gonzalez BF, Zisi TF, Abreu MM, Masina R, Sha D, Najjar M, et al.
(2019). CCL21 Expression in beta-Cells Induces Antigen-Expressing
Stromal Cell Networks in the Pancreas and Prevents Autoimmune Diabetes
in Mice. Diabetes 68: 1990-2003.
Goto M, & Liu M. (2020). Chemokines and their receptors as biomarkers
in esophageal cancer. Esophagus 17: 113-121.
Griffith JW, Sokol CL, & Luster AD. (2014). Chemokines and chemokine
receptors: positioning cells for host defense and immunity. Annu Rev
Immunol 32: 659-702.
Han L, Zhang XZ, Wang C, Tang XY, Zhu Y, Cai XY, et al. (2020).
IgD-Fc-Ig fusion protein, a new biological agent, inhibits T cell
function in CIA rats by inhibiting IgD-IgDR-Lck-NF-kappaB signaling
pathways. Acta Pharmacol Sin 41: 800-812.
Hauser MA, & Legler DF. (2016). Common and biased signaling pathways of
the chemokine receptor CCR7 elicited by its ligands CCL19 and CCL21 in
leukocytes. J Leukoc Biol 99: 869-882.
Hayashi H, Nakagami H, Takami Y, Koriyama H, Mori M, Tamai K, et al.
(2009). FHL-2 suppresses VEGF-induced phosphatidylinositol 3-kinase/Akt
activation via interaction with sphingosine kinase-1. Arterioscler.
Thromb Vasc Biol 29: 909-914.
Hoffmann-Vold AM, Hesselstrand R, Fretheim H, Ueland T, Andreassen AK,
Brunborg C, et al. (2018). CCL21 as a Potential Serum Biomarker for
Pulmonary Arterial Hypertension in Systemic Sclerosis. Arthritis Rheum
70: 1644-1653.
Hons M, Kopf A, Hauschild R, Leithner A, Gaertner F, Abe J, et al.
(2018). Chemokines and integrins independently tune actin flow and
substrate friction during intranodal migration of T cells. Nat Immunol
19: 606-616.
Jiang Y, Bai J, Tang L, Zhang P, & Pu J. (2015). Anti-CCL21 antibody
attenuates infarct size and improves cardiac remodeling after myocardial
infarction. Cell Physiol Biochem 37: 979-990.
Jiang BH, & Liu LZ. (2008). AKT signaling in regulating angiogenesis.
Curr Cancer Drug Targets 8: 19-26.
Joutoku Z, Onodera T, Matsuoka M, Homan K, Momma D, Baba R, et al.
(2019). CCL21/CCR7 axis regulating juvenile cartilage repair can enhance
cartilage healing in adults. Sci Rep 9: 5165.
Klammt C, Novotna L, Li DT, Wolf M, Blount A, Zhang K, et al.
Lillemeier. (2015). T cell receptor dwell times control the kinase
activity of Zap70. Nat Immunol 16: 961-969.
Korbecki J, Grochans S, Gutowska I, Barczak K, & Baranowska-Bosiacka I.
(2020). CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer
Properties of Receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 Ligands.
Int J Mol Sci 21: 7619.
Kuwabara T, Tanaka Y, Ishikawa F, Kondo M, Sekiya H, & Kakiuchi T.
(2012). CCR7 ligands up-regulate IL-23 through PI3-kinase and NF-kappa B
pathway in dendritic cells. J Leukoc Biol 92: 309-318.
Kuwabara T, Ishikawa F, Yasuda T, Aritomi K, Nakano H, Tanaka Y, et al.
(2009). CCR7 ligands are required for development of experimental
autoimmune encephalomyelitis through generating IL-23-dependent Th17
cells. J Immunol 183: 2513-2521.
Laufer JM, & Legler DF. (2018). Beyond migration-Chemokines in
lymphocyte priming, differentiation, and modulating effector functions.
J Leukoc Biol 104: 301-312.
Lee KE, Kang JH, Yim YR, Kim JE, Lee JW, Wen L, et al. (2017).
Predictive significance of CCL21 and CXCL13 levels in the minor salivary
glands of patients with Sjogren’s syndrome. Clin Exp Rheumatol 35:
234-240.
Legler DF, & Thelen M. (2016). Chemokines: Chemistry, Biochemistry and
Biological Function. Chimia (Aarau) 70: 856-859.
Liang Y, Tsoi LC, Xing X, Beamer MA, Swindell WR, Sarkar MK, et al.
(2017). A gene network regulated by the transcription factor VGLL3 as a
promoter of sex-biased autoimmune diseases. Nat Immunol 18: 152-160.
Li P, Liu F, Sun L, Zhao Z, Ding X, Shang D, et al. (2011). Chemokine
receptor 7 promotes cell migration and adhesion in metastatic squamous
cell carcinoma of the head and neck by activating integrin alphavbeta3.
Int J Mol Med 27: 679-687.
Li BH, Garstka MA, & Li ZF. (2020). Chemokines and their receptors
promoting the recruitment of myeloid-derived suppressor cells into the
tumor. Mol Immunol 117: 201-215.
Li G, Zhao J, Li B, Ma J, Zhao Q, Wang X, et al. (2017). Associations
between CCL21 gene polymorphisms and susceptibility to rheumatoid
arthritis: a meta-analysis. Rheumatol Int 37: 1673-1681.
Liu J, Wei Y, Luo Q, Xu F, Zhao Z, Zhang H, et al. (2016). Baicalin
attenuates inflammation in mice with OVA-induced asthma by inhibiting
NF-kappaB and suppressing CCR7/CCL19/CCL21. Int J Mol Med 38: 1541-1548.
Lou Y, Zheng Y, Xu Y, Lu H, Wang Y, & Guo Y. (2021). Association of
serum chemokine ligand 21 levels with asthma control in adults. Clinics
(Sao Paulo) 76: e1713.
Luo Q, Zhang B, Kuang D, & Song G. (2016). Role of Stromal-Derived
Factor-1 in Mesenchymal Stem Cell Paracrine-Mediated Tissue Repair. Curr
Stem Cell Res Ther 11: 585-592.
Luo H, Su J, Sun R, Sun Y, Wang Y, Dong Y, et al. (2020). Coexpression
of IL7 and CCL21 Increases Efficacy of CAR-T Cells in Solid Tumors
without Requiring Preconditioned Lymphodepletion. Clin Cancer Res 26:
5494-5505.
Lv J, Li L, Li W, Ji K, Hou Y, Yan C, et al. (2018). Role of the
chemokine receptors CXCR3, CXCR4 and CCR7 in the intramuscular
recruitment of plasmacytoid dendritic cells in dermatomyositis. J
Neuroimmunol 319: 142-148.
MacDonald IJ, Liu SC, Su CM, Wang YH, Tsai CH, Tang CH. (2018).
Implications of Angiogenesis Involvement in Arthritis. Int J Mol Sci 19:
2012.
McHugh J. (2019). CCL21-CCR7 axis in RA: linking inflammation and bone
erosion. Nat Rev Rheumatol 15: 576.
Miller FW, Cooper RG, Vencovsky J, Rider LG, Danko K, Wedderburn LR, et
al. (2013). Genetics. Consortium. Genome-wide association study of
dermatomyositis reveals genetic overlap with other autoimmune disorders.
Arthritis Rheum 65: 3239-3247.
Mircheff AK, Wang Y, Pan BX, Parsa L, Nandoskar P, & Ding C. (2019).
Molecular Evidence for Precursors of Sjogren’s Foci in Histologically
Normal Lacrimal Glands. In. J Mol Sci 20: 223.
Mircheff AK, Wang Y, Ding C, Warren DW, & Schechter JE. Schechter.
(2015). Potentially pathogenic immune cells and networks in apparently
healthy lacrimal glands. Ocul Surf 13: 47-81.
Mollica PV, Massara M, Capucetti A, & Bonecchi R. (2019). Chemokines
and Chemokine Receptors: New Targets for Cancer Immunotherapy. Front
Immunol 10: 379.
Moschovakis GL, Bubke A, Friedrichsen M, Ristenpart J, Back JW, Falk CS,
et al. (2019). The chemokine receptor CCR7 is a promising target for
rheumatoid arthritis therapy. Cell Mol Immunol 16: 791-799.
Nagarsheth N, Wicha MS, & Zou W. (2017). Chemokines in the cancer
microenvironment and their relevance in cancer immunotherapy. Nat Rev
Immunol 17: 559-572.
Nomiyama H, Osada N, & Yoshie O. (2013). Systematic classification of
vertebrate chemokines based on conserved synteny and evolutionary
history. Genes Cells 18: 1-16.
Odler B, Bikov A, Streizig J, Balogh C, Kiss E, Vincze K, et al. (2017).
CCL21 and IP-10 as blood biomarkers for pulmonary involvement in
systemic lupus erythematosus patients. Lupus 26: 572-579.
Park MS, Kim YH, Jung Y, Kim SH, Park JC, Yoon DS, et al. (2015). In
Situ Recruitment of Human Bone Marrow-Derived Mesenchymal Stem Cells
Using Chemokines for Articular Cartilage Regeneration. Cell Transplant
24: 1067-1083.
Pickens SR, Chamberlain ND, Volin MV, Pope RM, Mandelin AN, & Shahrara
S. (2011). Characterization of CCL19 and CCL21 in rheumatoid arthritis.
Arthritis Rheum 63: 914-922.
Pickens SR, Chamberlain ND, Volin MV, Pope RM, Talarico NE, Mandelin AM,
et al. (2012). Shahrara. Role of the CCL21 and CCR7 pathways in
rheumatoid arthritis angiogenesis. Arthritis Rheum 64: 2471-2481.
Psianou K, Panagoulias I, Papanastasiou AD, de Lastic AL, Rodi M,
Spantidea PI, et al. (2018). Clinical and immunological parameters of
Sjogren’s syndrome. Autoimmun Rev 17: 1053-1064.
Qi S, Liu G, Dong X, Huang N, Li W, & Chen H. (2018). Microarray data
analysis to identify differentially expressed genes and biological
pathways associated with asthma. Exp Ther Med 16: 1613-1620.
Qin Y, He LD, Sheng ZJ, Yong MM, Sheng YS, Wei DX, et al. (2014).
Increased CCL19 and CCL21 levels promote fibroblast ossification in
ankylosing spondylitis hip ligament tissue. Bmc Musculoskelet Disord 15:
316.
Ridiandries A, Tan J, & Bursill CA. (2018). The Role of Chemokines in
Wound Healing. Int J Mol Sci 19: 3217.
Rider LG, & Nistala K. (2016). The juvenile idiopathic inflammatory
myopathies: pathogenesis, clinical and autoantibody phenotypes, and
outcomes. J Inter. Med 280: 24-38.
Rischmueller M, Tieu J, & Lester S. (2016). Primary Sjogren’s syndrome.
Best Pract Res Clin Rheumatol 30: 189-220.
Rizeq B, & Malki MI. (2020). The Role of CCL21/CCR7 Chemokine Axis in
Breast Cancer Progression. Cancers (Basel) 12: 1036.
Rong Y, Chen X, Fan D, Lin X, Zheng X, Zhou C, et al. (2017).
[Influence of CCL21 on the invasion and metastasis of colorectal
cancer]. Zhonghua Wei Chang Wai Ke Za Zhi 20: 1300-1305.
Ruez R, Dubrot J, Zoso A, Bacchetta M, Molica F, Hugues S, et al.
(2018). Dendritic Cell Migration Toward CCL21 Gradient Requires
Functional Cx43. Front Phusiol 9: 288.
Ruytinx P, Proost P, Van Damme J, & Struyf S. (2018). Chemokine-Induced
Macrophage Polarization in Inflammatory Conditions. Front Immunol 9:
1930.
Salem A, Alotaibi M, Mroueh R, Basheer HA, & Afarinkia K. (2021). CCR7
as a therapeutic target in Cancer. Biochim Biophys Acta Rev Cancer 1875:
188499.
Shi M, Chen D, Yang D, & Liu XY. (2015). CCL21-CCR7 promotes the lymph
node metastasis of esophageal squamous cell carcinoma by up-regulating
MUC. J Exp Clin Cancer Res 34: 149.
Singh N, & Sundar S. (2017). Inflammatory chemokines and their
receptors in human visceral leishmaniasis: Gene expression profile in
peripheral blood, splenic cellular sources and their impact on
trafficking of inflammatory cells. Mol Immunol 85: 111-119.
Sokol CL, & Luster AD. (2015). The chemokine system in innate immunity.
Cold Spring Harb Perspect Biol 7: a016303.
Stacer AC, Fenner J, Cavnar SP, Xiao A, Zhao S, Chang SL, et al. (2016).
Endothelial CXCR7 regulates breast cancer metastasis. Oncogene 35:
1716-1724.
Stone MJ, Hayward JA, Huang C, E Huma Z, & Sanchez J. (2017).
Mechanisms of Regulation of the Chemokine-Receptor Network. Int J Mol
Sci 18: 342.
Sulicka J, Surdacki A, Korkosz M, Mikolajczyk T, Strach M, Klimek E, et
al. (2017). Endothelial dysfunction is independent of inflammation and
altered CCR7 T cell expression in patients with ankylosing spondylitis.
Clin Exp Rheumatol 35: 844-849.
Tandon M, Perez P, Burbelo PD, Calkins C, & Alevizos I. (2017). Laser
microdissection coupled with RNA-seq reveal cell-type and
disease-specific markers in the salivary gland of Sjogren’s syndrome
patients. Clin Exp Rheumatol 35: 777-785.
Tripathi DK, & Poluri KM. (2020). Molecular insights into kinase
mediated signaling pathways of chemokines and their cognate G protein
coupled receptors. Front Biosci (Landmark Ed) 25: 1361-1385.
Tutunea-Fatan E, Majumder M, Xin X, & Lala PK. (2015). The role of
CCL21/CCR7 chemokine axis in breast cancer-induced lymphangiogenesis.
Mol Cancer 14: 35.
Van Raemdonck K, Umar S, Palasiewicz K, Volkov S, Volin MV, Arami S, et
al. (2020). CCL21/CCR7 signaling in macrophages promotes joint
inflammation and Th17-mediated osteoclast formation in rheumatoid
arthritis. Cell Mol Life Sci 77: 1387-1399.
Van Raemdonck K, Umar S, & Shahrara S. (2020). The pathogenic
importance of CCL21 and CCR7 in rheumatoid arthritis. Cytokine Growth
Factor Rev 55: 86-93.
Voruganti A, & Bowness P. (2020). New developments in our understanding
of ankylosing spondylitis pathogenesis. Immunology 161: 94-102.
Vanden BW. (2014). In situ tissue regeneration: chemoattractants for
endogenous stem cell recruitment. Tissue Eng Part B Rev 20: 28-39.
Watanabe T, Suzuki J, Mitsuo A, Nakano S, Tamayama Y, Katagiri A, et al.
(2008). Striking alteration of some populations of T/B cells in systemic
lupus erythematosus: relationship to expression of CD62L or some
chemokine receptors. Lupus 17: 26-33.
Wasilko DJ, Johnson ZL, Ammirati M, Che Y, Griffor MC,Han S, et al.
(2020). Structural basis for chemokine receptor CCR6 activation by the
endogenous protein ligand CCL20. Nat. Commun. 11: 3031.
Wei Y, Liu J, Zhang H, Du X, Luo Q, Sun J, et al. (2016). Ligustrazine
attenuates inflammation and the associated chemokines and receptors in
ovalbumine-induced mouse asthma model. Environ Toxicol Pharmacol 46:
55-61.
Wieczorek S, Holle JU, Muller S, Fricke H, Gross WL, & Epplen JT.
(2010). A functionally relevant IRF5 haplotype is associated with
reduced risk to Wegener’s granulomatosis. J Mol Med (Berl) 88: 413-421.
Worbs T, Hammerschmidt SI, & Forster R. (2017). Dendritic cell
migration in health and disease. Nat Rev Immunol 17: 30-48.
Xiao ZX, Miller JS, & Zheng SG. (2021). An updated advance of
autoantibodies in autoimmune diseases. Autoimmun Rev 20: 102743.
Xia X, Liu K, Zhang H, & Shang Z. (2015). Correlation between CCR7
expression and lymph node metastatic potential of human tongue
carcinoma. Oral Dis 21: 123-131.
Xiong Y, Huang F, Li X, Chen Z, Feng D, Jiang H, et al. (2017).
CCL21/CCR7 interaction promotes cellular migration and invasion via
modulation of the MEK/ERK1/2 signaling pathway and correlates with
lymphatic metastatic spread and poor prognosis in urinary bladder
cancer. Int J Oncol 51: 75-90.
Xu Y, Lee PY, Li Y, Liu C, Zhuang H, Han S, et al. (2012). Pleiotropic
IFN-dependent and -independent effects of IRF5 on the pathogenesis of
experimental lupus. J Immunol 188: 4113-4121.
Yu CL, Yang CH, & Chi CC. (2020). Drug Survival of Biologics in
Treating Ankylosing Spondylitis: A Systematic Review and Meta-analysis
of Real-World Evidence. Biodrugs 34: 669-679.
Yu S, Hou Q, Sun H, Liu J, & Li J. (2015). Upregulation of C-C
chemokine receptor type 7 expression by membrane-associated
prostaglandin E synthase-1/prostaglandin E2 requires glycogen synthase
kinase 3beta-mediated signal transduction in colon cancer cells. Mol Med
Rep 12: 7169-7175.
Zhang L, & Wei W. (2020). Anti-inflammatory and immunoregulatory
effects of paeoniflorin and total glucosides of paeony. Pharmacol. Ther.
207: 107452.
Zhang J, Wang N, & Xu A. (2018). Screening of genes associated with
inflammatory responses in the endolymphatic sac reveals underlying
mechanisms for autoimmune inner ear diseases. Exp Ther Med 16:
2460-2470.
Zhang YY, Liu ZB, Ye XG, & Ren WM. (2016). Iodine regulates G2/M
progression induced by CCL21/CCR7 interaction in primary cultures of
papillary thyroid cancer cells with RET/PTC expression. Mol Med Rep 14:
3941-3946.
Zhang JF, Li Y, Zhang AZ, He QQ, Du YC, & Cao W. (2018). Expression and
pathological significance of CC chemokine receptor 7 and its ligands in
the airway of asthmatic rats exposed to cigarette smoke. J Thorac Dis
10: 5459-5467.
Zhao W, Li D, Su Y, Zhao H, Pang W, Sun Y, et al. (2019). MicroRNA-147
negatively regulates expression of toll-like receptor-7 in rat
macrophages and attenuates pristane induced rheumatoid arthritis in
rats. Am J Transl Res 11: 2219-2231.
Zhong G, Chen L, Yin R, Qu Y, Bao Y, Xiao Q, et al. (2017). Chemokine
(CC motif) ligand 21/CC chemokine receptor type 7 triggers migration and
invasion of human lung cancer cells by epithelialmesenchymal transition
via the extracellular signalregulated kinase signaling pathway. Mol Med
Rep 15: 4100-4108.
Zlotnik A, & Yoshie O. (2012). The chemokine superfamily revisited.
Immunity 36: 705-716.